Verrica receives Nasdaq delisting notice, implements 1-for-10 reverse split to regain bid price compliance

Verrica Pharmaceuticals Inc.

Nasdaq Staff Determination issued July 24, 2025; company may request hearing to stay delisting.
1-for-10 reverse stock split effected July 24, 2025 to increase per-share bid price.
Closing bid price $6.24 on July 29, 2025, above $1.00 minimum for 4 consecutive business days.
Company will request bid price compliance determination after 10 trading days of compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.